Elekta AB Unsponsored American Depositary Receipt Logo

Elekta AB Unsponsored American Depositary Receipt (EKTAY)

OTC

Currency in USD
5.72
-0.15 (-2.56%)

Closed

Aug 26, 2026

Day's Range

5.72
5.72

52 wk Range

4.35
6.93

Overview - EKTAY - Elekta AB Unsponsored American Depositary Receipt

Key Statistics

Valuation

Enterprise Value

6.34B

P/E (Trailing)

‪75.62‬

PEG Ratio

‪0.60‬

Price / Sales (TTM)

‪0.13‬

Price / Book

‪0.26‬

EV / EBITDA

‪4.18‬

Profitability

Gross Margin

‪39.52%‬

Profit Margin

‪-3.10%‬

Operating Margin

‪0.97%‬

Return on Assets

‪3.05%‬

Return on Equity

‪-6.45%‬

Ownership

Shares Outstanding

382.08M

Float

311.09M

Held by Insiders

‪0.00%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪0.96‬

50-Day Avg

‪5.17‬

200-Day Avg

‪5.74‬

Dividends

Payout Ratio

‪327.57%‬

Frequency

Semi-Annual

Shariah Compliance

Shariah Compliant

Report Date: Feb 20, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - EKTAY - Elekta AB Unsponsored American Depositary Receipt

Peer Comparison

Compared with companies in Medical Devices listed on OTC.

Profile Summary - EKTAY - Elekta AB Unsponsored American Depositary Receipt

About

Elekta AB Unsponsored American Depositary Receipt represents shares in Elekta AB, a Swedish medical technology company that develops and provides advanced clinical solutions for the treatment of cancer and brain disorders. Through its specialized radiotherapy, brachytherapy, and neurosurgery products—including the…

SectorHealthcare
IndustryMedical Devices
Employees4.35K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.